etoposide has been researched along with Leiomyosarcoma in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 11 (78.57) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batár, P; Kiss, A; Kovácsné Kovács, E; Rejto, L; Reményi, G; Sípos, T; Szarvas, M; Szász, R; Udvardy, M; Váróczy, L | 1 |
Ishizuka, B; Kiguchi, K; Kobayashi, Y; Okuma, Y; Tozawa, A | 1 |
Chantarawiroj, P; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Silva, EG; Tresukosol, D; Wharton, JT | 1 |
Fukunishi, H; Kitazawa, S; Takeuchi, S; Yukimura, N | 1 |
Baker, LH; Blair, SC; Zalupski, MM | 1 |
Koshiba, K; Mukai, N; Rokkaku, S; Soh, S; Uchida, T | 1 |
Berman, M; Blessing, JA; Burke, TW; Currie, J; Fowler, J; Muss, HB | 1 |
Amenta, P; Drachtman, RA; Ettinger, LJ; Han, P | 1 |
Blessing, JA; Thigpen, T; Vaccarello, L; Valea, F; Yordan, E | 1 |
Carcangiu, ML; Chambers, IT; Chambers, SK; Kohorn, EI; Resnik, E; Schwartz, PE | 1 |
Edwards, CL; Kavanagh, JJ; Kudelka, AP; Piamsomboon, S; Termrungruanglert, W; Tornos, C | 1 |
Bertz, H; Brugger, W; Fetscher, S; Kanz, L; Krieger, G; Lange, W; Mertelsmann, R | 1 |
Barter, JF; Blessing, JA; Rose, PG; Soper, JT | 1 |
Angel, C; Berman, M; Blessing, JA; Slayton, RE | 1 |
4 trial(s) available for etoposide and Leiomyosarcoma
Article | Year |
---|---|
Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Leiomyosarcoma; Male; Middle Aged; Sarcoma; Survival Analysis | 1994 |
Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etoposide; Female; Humans; Hydroxyurea; Leiomyosarcoma; Middle Aged; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 1996 |
Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Injections, Intravenous; Leiomyosarcoma; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 1996 |
Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Uterine Neoplasms | 1998 |
10 other study(ies) available for etoposide and Leiomyosarcoma
Article | Year |
---|---|
[One hundred fifty autologous peripheral haemopoietic stem cell transplantations and their lessons].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hungary; International Cooperation; Kaplan-Meier Estimate; Leiomyosarcoma; Lymphoma, Non-Hodgkin; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2009 |
Complete remission with intraperitoneal cisplatin followed by prolonged oral etoposide in a stage IIIc primary leiomyosarcoma of the fallopian tube patient.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Injections, Intraperitoneal; Leiomyosarcoma; Neoplasm Staging; Remission Induction; Treatment Outcome | 2010 |
Prolonged oral etoposide for refractory advanced uterine leiomyosarcoma.
Topics: Administration, Oral; Aged; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Infusions, Intravenous; Leiomyosarcoma; Neoplasm Recurrence, Local; Uterine Neoplasms | 1995 |
Uterine myxoid leiomyosarcoma and CYVADIC-etoposide therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Etoposide; Fatal Outcome; Female; Humans; Hysterectomy; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Mitotic Index; Treatment Outcome; Uterine Neoplasms; Vincristine | 1994 |
[Leiomyosarcoma of the prostate: response to treatment with cisplatin, etoposide and methotrexate chemotherapy: a case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Methotrexate; Prostatic Neoplasms | 1994 |
Successful treatment of a primary cardiac leiomyosarcoma with ifosfamide and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Heart Neoplasms; Humans; Ifosfamide; Infant; Leiomyosarcoma; Mesna; Microscopy, Electron; Time Factors | 1996 |
Malignant uterine smooth muscle tumors: role of etoposide, cisplatin, and doxorubicin (EPA) chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leiomyosarcoma; Middle Aged; Myometrium; Neoplasms, Muscle Tissue; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 1996 |
Prolonged oral etoposide for advanced uterine leiomyosarcoma with pulmonary metastases: case report.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Uterine Neoplasms | 1997 |
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leiomyosarcoma; Stomach Neoplasms | 1997 |
Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Etoposide; Female; Humans; Leiomyosarcoma; Middle Aged; Uterine Neoplasms | 1987 |